A Study to Evaluate the Efficacy and Toxicities of PLX038, in Patients With Locally Advanced or Metastatic Triple-negative Breast Cancer
Clinical trial NCT06162351 · TERMINATED
Trial details
- NCT number
- NCT06162351
- Sponsor
- Institut Curie
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-17
- Primary completion
- 2025-05-15
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.